A double-blind, placebo-controlled, single and multiple, dose-escalating, phase I study to assess the safety and tolerability of inhaled interferon-beta (IFN-beta1a) in controlled asthmatic male and female subjects

Trial Profile

A double-blind, placebo-controlled, single and multiple, dose-escalating, phase I study to assess the safety and tolerability of inhaled interferon-beta (IFN-beta1a) in controlled asthmatic male and female subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 16 Nov 2016

At a glance

  • Drugs Interferon beta-1a (Primary)
  • Indications Asthma; Viral infections
  • Focus Adverse reactions
  • Sponsors Synairgen
  • Most Recent Events

    • 02 Sep 2009 Status changed from active, no longer recruiting to completed as reported by ISRCTN: Current Controlled Trials.
    • 02 Sep 2009 Actual end date (Sep 2009) added as reported by ISRCTN: Current Controlled Trials.
    • 02 Mar 2009 Status changed from recruiting to active, no longer recruiting, as reported in IRSCTN record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top